Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial-Reference-Cited by-同舟云学术

Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial

Published:2017-05 Issue:10081 Volume:389 Page:1799-1808
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Ohman E Magnus,Roe Matthew T,Steg P Gabriel,James Stefan K,Povsic Thomas J,White Jennifer,Rockhold Frank,Plotnikov Alexei,Mundl Hardi,Strony John,Sun Xiang,Husted Steen,Tendera Michal,Montalescot Gilles,Bahit M Cecilia,Ardissino Diego,Bueno Héctor,Claeys Marc J,Nicolau Jose C,Cornel Jan H,Goto Shinya,Kiss Róbert Gábor,Güray Ümit,Park Duk-Woo,Bode Christoph,Welsh Robert C,Gibson C Michael

Publisher

Elsevier BV

Subject

General Medicine

Reference33 articles.

1. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2;Lancet,1988

2. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials;Lancet,2009

3. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation;Yusuf;N Engl J Med,2001

4. Prasugrel versus clopidogrel in patients with acute coronary syndromes;Wiviott;N Engl J Med,2007

5. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;Wallentin;N Engl J Med,2009

Cited by 184 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Potential of FXI Inhibitors: Hype or Hope?;Drugs;2024-07-29

2. Clinical Follow-Up of Patients after Coronary Artery Bypass Grafting;Cardiology and Cardiovascular Medicine;2024-06-19

3. Efficacy and Safety of Combination Therapy with Low-Dose Rivaroxaban in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Journal of Clinical Medicine;2024-03-31

4. The Net Clinical Outcome of Dual-Pathway Inhibition in Clinical Practice: The “Xarelto plus Acetylsalicylic Acid: Treatment Patterns and Outcomes in Patients with Atherosclerosis” Registry;Journal of Clinical Medicine;2024-03-28

5. Chinese expert consensus on anti-thrombotic therapy for pan-vascular diseases (2023 edition);Cardiology Plus;2024-03-22